Tag: release

SINGAPORE, July 11, 2025 (GLOBE NEWSWIRE) -- DexLab, the leading Solana-native token launching & tooling platform, today announced the launch of its fully independent Asia-Pacific subsidiary CaLab. Built on DexLab's battle-tested technical infrastructure, CaLab will operate as a regional powerhouse focused on serving APAC markets while maintaining technological interoperability with its parent platform.

MONTREAL, July 11, 2025 (GLOBE NEWSWIRE) -- Stingray Group Inc. (TSX: RAY.A; RAY.B) will release its financial results for the first quarter ended June 30, 2025, on Tuesday, August 5^th, 2025, after the markets close. Management will hold a conference call to discuss the financial results the next day, August 6, 2025, at 9:00 a.m. Eastern Time.

SHANGHAI, July 11, 2025 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility technology provider, today announced it has entered into a global strategic partnership with Samsung Group (“Samsung”), marking a new phase in their collaboration. This strengthened partnership will accelerate the commercialization of cutting-edge automotive intelligence technologies across automotive intelligence, terminal devices, and smart hardware, with the aim of building a sustainable open technology ecosystem that will also capitalize on opportunities in the rapidly growing robotics and AI applications markets.

ALPHARETTA, GA, July 11, 2025 (GLOBE NEWSWIRE) -- Ashton Woods USA L.L.C. (the “Company”) announced today that the Company’s Annual Report for the fiscal year ended May 31, 2025 (the “Annual Report”) is expected to be posted on the Company’s website on or before Thursday, July 17, 2025. The Company will host a conference call on Thursday, July 17, 2025, at 11:00 AM EDT for the purpose of discussing the Annual Report and the Company’s operating results for the fiscal year ended May 31, 2025.

CAISSES LOCALES AFFILIÉES
À LA CAISSE REGIONALE DE CRÉDIT AGRICOLE MUTUEL
NORMANDIE SEINE

MONTREAL, Quebec and CHARLOTTE, N.C., July 11, 2025 (GLOBE NEWSWIRE) -- Milestone^® Pharmaceuticals Inc. (“Milestone”) (Nasdaq: MIST) today announced that it has commenced an underwritten public offering (the “Offering”) of its common shares, accompanying Series A warrants to purchase common shares (the “Series A Warrants”) and accompanying Series B warrants to purchase common shares (the “Series B Warrants”), and, in lieu of common shares to certain investors that so choose, pre-funded warrants to purchase common shares, accompanying Series A Warrants and accompanying Series B warrants. All securities to be sold in the Offering will be sold by Milestone. The Offering is subject to market and other conditions and there can be no assurance as to whether or when the Offering may be completed, or as to the actual size or terms of the Offering.